Higher mortality in postmenopausal women with RA and anti-CCP antibodies

New research shows mortality rates are two times higher in postmenopausal women with rheumatoid arthritis and anti-cyclic citrullinated peptide antibodies. Findings published in the American College of Rheumatology journal Arthritis & Rheumatism, soon to be called Arthritis & Rheumatology, indicate the higher mortality rates persisted after adjusting for age, positive rheumatoid factor, positive antinuclear antibodies and disease modifying anti-rheumatic drug use.

Fuente : http://www.eurekalert.org/pub_releases/2013-12/w-h…